Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Hexadecanamide, N-(1-methylethyl)- REF: IN-DA002E4WCAS: 189939-61-5 | 98% | 103.00 €~474.00 € | Thu 05 Dec 24 | |
Palmitoylisopropylamide REF: 3D-FP26735CAS: 189939-61-5 | Min. 95% | To inquire | Thu 16 Jan 25 | |
Palmitoylisopropylamide REF: TM-T23119CAS: 189939-61-5 | 100% | 41.00 €~1,276.00 € | Thu 23 Jan 25 | |
Palmitoylisopropylamide REF: TR-P158000CAS: 189939-61-5 | - - - | - - - | Discontinued product |
Hexadecanamide, N-(1-methylethyl)-
CAS:189939-61-5
Formula:
C19H39NO
Purity:
98%
Molecular weight:
297.5191
Ref: IN-DA002E4W
5mg | 103.00 € | ||
10mg | 123.00 € | ||
25mg | 179.00 € | ||
50mg | 298.00 € | ||
100mg | 474.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Palmitoylisopropylamide
CAS:189939-61-5
Palmitoylisopropylamide is a molecule that has two amide groups. It also contains a hydroxyl group …
Formula:
C19H39NO
Purity:
Min. 95%
Molecular weight:
297.52 g/mol
Ref: 3D-FP26735
1g | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire | ||
500mg | To inquire |
Estimated delivery in United States, on Thursday 16 Jan 2025
Palmitoylisopropylamide
CAS:189939-61-5
Palmitoylisopropylamide is a selective FAAH inhibitor that inhibits [H]-AEA uptake and cell proliferation at low …
Formula:
C19H39NO
Purity:
100%
Color and Shape:
Solid
Molecular weight:
297.52
Ref: TM-T23119
1mg | 41.00 € | ||
5mg | 82.00 € | ||
10mg | 106.00 € | ||
25mg | 211.00 € | ||
50mg | 422.00 € | ||
100mg | 613.00 € | ||
500mg | 1,276.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
Palmitoylisopropylamide
Controlled ProductCAS:189939-61-5
Applications An inhibitor of fatty acid amide hydrolase (FAAH). pIC50=4.89 for inhibition of [3H]-anandamide metabolism. …
Formula:
C19H39NO
Color and Shape:
Neat
Molecular weight:
297.52
Ref: TR-P158000
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |